Publicaciones en colaboración con investigadores/as de University College London (12)

2021

  1. Comparison of flipped learning and traditional lecture method for teaching digestive system diseases in undergraduate medicine: A prospective non-randomized controlled trial

    Medical Teacher, Vol. 43, Núm. 4, pp. 463-471

2020

  1. KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation

    Kidney International

  2. KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

    Kidney International

2018

  1. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    The Lancet Neurology, Vol. 17, Núm. 5, pp. 405-415

2014

  1. Fatty kidney: Emerging role of ectopic lipid in obesity-related renal disease

    The Lancet Diabetes and Endocrinology, Vol. 2, Núm. 5, pp. 417-426

  2. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2012

  1. COGENT (COlorectal cancer GENeTics) revisited

    Mutagenesis, Vol. 27, Núm. 2, pp. 143-151

  2. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  3. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2095-2128

  4. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196

2009

  1. An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 9, pp. 1433-1439

2007

  1. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor

    New England Journal of Medicine, Vol. 356, Núm. 3, pp. 237-247